Fibroblast

Chicago, United States Founded: 2011 • Age: 15 yrs Acquired By Cerner
Patient referral processes are automated by Fibroblasts SaaS platform.
Request Access

About Fibroblast

Fibroblast is a company based in Chicago (United States) founded in 2011 was acquired by Cerner in October 2020.. Fibroblast has raised $3.23 million across 4 funding rounds from investors including Cerner and Excelerator Titan. Fibroblast operates in a competitive market with competitors including eHealth Technologies, RubiconMD, Refer Well, Clarity Health and par8o, among others.

  • Headquarter Chicago, United States
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Fibroblast, Inc.
Operational Areas
Healthcare → Health Technology & Digital Health
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $3.23 M (USD)

    in 4 rounds

  • Latest Funding Round
    $500 K (USD), Seed

    Jan 15, 2020

  • Investors
    Cerner

    & 1 more

  • Employee Count
    Employee Count
  • Acquired by
    Cerner

    (Oct 01, 2020)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Fibroblast

Fibroblast has successfully raised a total of $3.23M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $500 thousand completed in January 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 4
  • Last Round Seed — $500,000
  • First Round
  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Jan, 2020 Amount Seed - Fibroblast Valuation

investors

Jan, 2018 Amount Seed - Fibroblast Valuation

investors

Oct, 2013 Amount Seed - Fibroblast Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Fibroblast

Fibroblast has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Cerner and Excelerator Titan. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Startups are accelerated through a 13-week program in Chicago.
Founded Year Domain Location
Online platform for employee health benefits
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Fibroblast

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Fibroblast

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Fibroblast Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Fibroblast

Fibroblast operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eHealth Technologies, RubiconMD, Refer Well, Clarity Health and par8o, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Referral solutions for healthcare providers
domain founded_year HQ Location
Remote consults are enabled between primary care physicians and specialists.
domain founded_year HQ Location
Cloud-based platform for healthcare referral management is provided.
domain founded_year HQ Location
Care coordination solutions are delivered to healthcare organizations.
domain founded_year HQ Location
Patient referrals are managed via cloud-based analytics and mobile alerts.
domain founded_year HQ Location
Cloud-based care coordination software is provided for healthcare professionals.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Fibroblast

Frequently Asked Questions about Fibroblast

When was Fibroblast founded?

Fibroblast was founded in 2011 and raised its 1st funding round 1 year after it was founded.

Where is Fibroblast located?

Fibroblast is headquartered in Chicago, United States. It is registered at Chicago, Illinois, United States.

Is Fibroblast a funded company?

Fibroblast is a funded company, having raised a total of $3.23M across 4 funding rounds to date. The company's 1st funding round was a Seed of $727.67K, raised on May 15, 2012.

What does Fibroblast do?

Fibroblast was founded in 2011 in Chicago, United States, and operates as a SaaS platform in the healthcare sector. Patient referrals are automated through the system, with tools provided for providers to manage referrals actively. Operations focus on reducing patient leakage, supporting revenue growth for fee-for-service entities, and mitigating risks for accountable care organizations across the United States.

Who are the top competitors of Fibroblast?

Fibroblast's top competitors include eHealth Technologies, RubiconMD and Refer Well.

Who are Fibroblast's investors?

Fibroblast has 2 investors. Key investors include Cerner, and Excelerator Titan.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available